Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component
- 1 August 1991
- journal article
- Published by Elsevier in The Lancet
- Vol. 338 (8763), 335-339
- https://doi.org/10.1016/0140-6736(91)90478-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.JCI Insight, 1990
- Evaluation of Systemic Amyloidosis by Scintigraphy with123I-Labeled Serum Amyloid P ComponentNew England Journal of Medicine, 1990
- Infarction of intestine with massive amyloid deposition in two patients on long-term hemodialysisGastroenterology, 1989
- Beta-2-Microglobulin Amyloidosis in Long-Term Dialysis PatientsAmerican Journal of Nephrology, 1989
- Gastrointestinal complications of dialysis related amyloidosis.BMJ, 1988
- DIAGNOSTIC RADIONUCLIDE IMAGING OF AMYLOID: BIOLOGICAL TARGETING BY CIRCULATING HUMAN SERUM AMYLOID P COMPONENTThe Lancet, 1988
- Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.The Journal of Experimental Medicine, 1988
- Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis.Journal of Clinical Pathology, 1987
- Beta-2 microglobulin is an amyloidogenic protein in man.JCI Insight, 1985
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985